These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 29786066

  • 1. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.
    Lisboa SF, Niraula A, Resstel LB, Guimaraes FS, Godbout JP, Sheridan JF.
    Neuropsychopharmacology; 2018 Aug; 43(9):1924-1933. PubMed ID: 29786066
    [Abstract] [Full Text] [Related]

  • 2. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
    Ganon-Elazar E, Akirav I.
    Psychoneuroendocrinology; 2013 Sep 24; 38(9):1675-87. PubMed ID: 23433741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced fear memory after social defeat in mice is dependent on interleukin-1 receptor signaling in glutamatergic neurons.
    Goodman EJ, Biltz RG, Packer JM, DiSabato DJ, Swanson SP, Oliver B, Quan N, Sheridan JF, Godbout JP.
    Mol Psychiatry; 2024 Aug 24; 29(8):2321-2334. PubMed ID: 38459193
    [Abstract] [Full Text] [Related]

  • 9. Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat.
    McKim DB, Patterson JM, Wohleb ES, Jarrett BL, Reader BF, Godbout JP, Sheridan JF.
    Biol Psychiatry; 2016 May 15; 79(10):803-813. PubMed ID: 26281717
    [Abstract] [Full Text] [Related]

  • 10. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
    Segev A, Rubin AS, Abush H, Richter-Levin G, Akirav I.
    Neuropsychopharmacology; 2014 Mar 15; 39(4):919-33. PubMed ID: 24141570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J.
    Neuropharmacology; 2012 Jun 15; 62(7):2299-308. PubMed ID: 22342378
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior.
    Wohleb ES, Patterson JM, Sharma V, Quan N, Godbout JP, Sheridan JF.
    J Neurosci; 2014 Feb 12; 34(7):2583-91. PubMed ID: 24523548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Influence of Microglial Elimination and Repopulation on Stress Sensitization Induced by Repeated Social Defeat.
    Weber MD, McKim DB, Niraula A, Witcher KG, Yin W, Sobol CG, Wang Y, Sawicki CM, Sheridan JF, Godbout JP.
    Biol Psychiatry; 2019 Apr 15; 85(8):667-678. PubMed ID: 30527629
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice.
    Wohleb ES, Fenn AM, Pacenta AM, Powell ND, Sheridan JF, Godbout JP.
    Psychoneuroendocrinology; 2012 Sep 15; 37(9):1491-505. PubMed ID: 22386198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.